Age, Biography and Wiki
Matthias Lütolf was born on 1973, is a Swiss biomedical engineer. Discover Matthias Lütolf's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 51 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
51 years old |
| Zodiac Sign |
N/A |
| Born |
|
| Birthday |
|
| Birthplace |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on .
He is a member of famous Engineer with the age 51 years old group.
Matthias Lütolf Height, Weight & Measurements
At 51 years old, Matthias Lütolf height not available right now. We will update Matthias Lütolf's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Matthias Lütolf Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Matthias Lütolf worth at the age of 51 years old? Matthias Lütolf’s income source is mostly from being a successful Engineer. He is from . We have estimated Matthias Lütolf's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Engineer |
Matthias Lütolf Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Matthias Lutolf (born in 1973, also known as Matthias Lütolf) is a bio-engineer and a professor at EPFL (École Polytechnique Fédérale de Lausanne) where he leads the Laboratory of Stem Cell Bioengineering.
He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models.
In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.
Lutolf studied materials engineering at ETH Zurich where he graduated in 1998.
In 2002, he received his PhD in biomedical engineering from ETH Zurich for his studies on cell-responsive hydrogels for tissue engineering and cell culture, in the group of Jeffrey Hubbell.
He completed postdoctoral studies in the laboratory of Helen Blau at Stanford University, where he worked on novel cell culture approaches for blood and muscle stem cells, so called synthetic niches.
In 2007, he founded his own laboratory at EPFL, where he was promoted to associate professor in 2014 and full professor in 2018.
In 2007, Lutolf received the European Young Investigator (EURYI) Award by the European Science Foundation.
From 2014 to 2018, he was director of EPFL's Institute of Bioengineering.
In June 2021, Lutolf became scientific director of the newly established Roche Institute for Translational Bioengineering in Basel, Switzerland.
Lutolf's laboratory develops in vitro organoids mimicking healthy and diseased tissues and organs.
Specifically, Lutolf uses bioengineering strategies to guide stem cell-based development to build novel organoids with improved reproducibility and physiological relevance for basic science and in vitro testing of drug candidates.
His team has developed approaches to generate organoids in fully controllable 3D matrices, and has contributed to the understanding of how extrinsic biochemical and physical factors control stem cell fate and organogenesis.
His team has developed concepts based on microfabrication, bioprinting, and microfluidics to improve the reproducibility, size, shape, and function of organoids.
Since 2018, he is elected as member of the European Molecular Biology Organization (EMBO).
He serves as associate editor of The Company of Biologists' journal Development.
